Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial

Overview of attention for article published in Frontiers in Nutrition, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 14 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 106 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 71,106 followers.

A randomised control trial conducted in 2022 tested the effects of the 5:2 (5 days normal:2 days fasted) method. 📉Results showed fibrosis and steatosis scores decreased. Liver enzymes results also decreased, reaching lower levels than the control group. h

29 Nov 2023

Reply Repost Favourite

RT @_INPST: intermittent fasting & non-alcoholic fatty liver disease

04 Sep 2022

Reply Repost Favourite

RT @_INPST: intermittent fasting & non-alcoholic fatty liver disease

04 Sep 2022

Reply Repost Favourite

RT @_INPST: intermittent fasting & non-alcoholic fatty liver disease

04 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.